Fennec Pharmaceuticals (FENC) Misses Q2 EPS by 6c

Fennec Pharmaceuticals (NASDAQ: FENC) reported Q2 EPS of ($0.19), $0.06 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026
• Is the S&P 500 in an "earnings bubble"? Goldman weighs in